1981
DOI: 10.1016/0006-291x(81)91644-2
|View full text |Cite
|
Sign up to set email alerts
|

Cis-aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
147
0

Year Published

1988
1988
2013
2013

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 265 publications
(149 citation statements)
references
References 4 publications
2
147
0
Order By: Relevance
“…17) These authors coupled daunorubicin to aminoethyl polyacrylamide polymer beads or poly-D-lysine using the aconityl spacer. Thereafter, a number of daunorubicin conjugates with monoclonal antibodies and synthetic polymers have been developed with this method.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…17) These authors coupled daunorubicin to aminoethyl polyacrylamide polymer beads or poly-D-lysine using the aconityl spacer. Thereafter, a number of daunorubicin conjugates with monoclonal antibodies and synthetic polymers have been developed with this method.…”
Section: Discussionmentioning
confidence: 99%
“…It has been suggested that most of the free g-carboxylic group of the aconityl spacer molecule is coupled to macromolecular moiety. 17) In this case the free g-carboxylic group may also participate to the coupling to PVA via ethylenediamine spacer, resulting the macromolecular conjugates of PVA-cis-ADOX and PVA-trans-ADOX, respectively. The conjugates were generated from the combination of PVA and DOX for the first time.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The release of free drug from carrier-drug conjugates by chemical hydrolysis at acid pH, which occurs for instance in endosomes and lysosomes of cells, can be accomplished by using the acid-labile cis-aconityl linkers introduced by Shen and Ryser [34]. We have prepared improved linkers allowing unequivocal binding of drug and carrier [ 11,12,20].…”
Section: Discussionmentioning
confidence: 99%